 Connection
Matthew Kelly to Anti-Bacterial Agents
This is a "connection" page, showing publications Matthew Kelly has written about Anti-Bacterial Agents.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.344 |
|
|
|
-
Hurst JH, Shaik-Dasthagirisaheb YB, Truong L, Boiditswe SC, Patel SM, Gilchrist J, Maciejewski J, Luinstra K, Smieja M, Steenhoff AP, Cunningham CK, Pelton SI, Kelly MS. Serotype epidemiology and antibiotic resistance of pneumococcal isolates colonizing infants in Botswana (2016-2019). PLoS One. 2024; 19(5):e0302400.
Score: 0.581
-
Heston SM, Young RR, Jenkins K, Martin PL, Stokhuyzen A, Ward DV, Bhattarai SK, Bucci V, Arshad M, Chao NJ, Seed PC, Kelly MS. The effects of antibiotic exposures on the gut resistome during hematopoietic cell transplantation in children. Gut Microbes. 2024 Jan-Dec; 16(1):2333748.
Score: 0.144
-
Hurst JH, Kelly MS. Leveraging the human microbiota to target bacterial respiratory pathogens: new paths toward an expanded antimicrobial armamentarium. mBio. 2023 08 31; 14(4):e0085423.
Score: 0.136
-
Gardiner SJ, Duffy EJ, Chambers ST, Thomas MG, Addidle M, Arnold B, Arroll B, Balm MN, Perales CB, Berger S, Best E, Betty B, Birch M, Blackmore TK, Bloomfield M, Briggs S, Bupha-Intr O, Burns A, Campbell C, Chin PK, Dalton SC, Davies N, Douglas NM, Plessis TD, Elvy J, Everts R, Green J, Grimwade K, Handy R, Hardie MG, Henderson E, Holland DJ, Howard J, Hudson B, Huggan P, Isenman H, Issa M, Kelly MJ, Li C, Lim AG, Lim J, Maze M, Metcalf SC, McCall C, Murdoch D, McRae G, Nisbet M, Pithie A, Raymond N, Read K, Restrepo D, Ritchie S, Robertson B, Ussher JE, Voss L, Walls T, Sen Yew H. Antimicrobial stewardship in human healthcare in Aotearoa New Zealand: urgent call for national leadership and co-ordinated efforts to preserve antimicrobial effectiveness. N Z Med J. 2021 10 22; 134(1544):113-128.
Score: 0.121
-
Tanaka JS, Young RR, Heston SM, Jenkins K, Spees LP, Sung AD, Corbet K, Thompson JC, Bohannon L, Martin PL, Stokhuyzen A, Vinesett R, Ward DV, Bhattarai SK, Bucci V, Arshad M, Seed PC, Kelly MS. Anaerobic Antibiotics and the Risk of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant. 2020 11; 26(11):2053-2060.
Score: 0.111
-
Pernica JM, Steenhoff AP, Mokomane M, Moorad B, Lechiile K, Smieja M, Mazhani L, Cheng J, Kelly MS, Loeb M, Stordal K, Goldfarb DM. Rapid enteric testing to permit targeted antimicrobial therapy, with and without Lactobacillus reuteri probiotics, for paediatric acute diarrhoeal disease in Botswana: A pilot, randomized, factorial, controlled trial. PLoS One. 2017; 12(10):e0185177.
Score: 0.092
-
Salerno S, Hornik CP, Cohen-Wolkowiez M, Smith PB, Ku LC, Kelly MS, Clark R, Gonzalez D. Use of Population Pharmacokinetics and Electronic Health Records to Assess Piperacillin-Tazobactam Safety in Infants. Pediatr Infect Dis J. 2017 Sep; 36(9):855-859.
Score: 0.091
-
Bradley JS, Makieieva N, T?ndel C, Roilides E, Kelly MS, Patel M, Vaddady P, Maniar A, Zhang Y, Paschke A, Chen LF. Pharmacokinetics, Safety, and Tolerability of Imipenem/Cilastatin/Relebactam in Children with Confirmed or Suspected Gram-Negative Bacterial Infections: A Phase?1b, Open-Label, Single-Dose Clinical Trial. J Clin Pharmacol. 2023 12; 63(12):1387-1397.
Score: 0.035
-
Hicks ED, Agada NO, Yates TR, Kelly MS, Tam JS, Ferdman RM, Dibernardo LR, Madden JF, Moody MA, Markert ML. Case Report: Nontuberculous mycobacterial infections in children with complete DiGeorge anomaly. Front Immunol. 2023; 14:1078976.
Score: 0.033
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|